Ultrasound Detection of Body Composition in Critical Care
Launched by AIN SHAMS UNIVERSITY · Dec 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how ultrasound can help doctors assess body composition changes in critically ill female patients. Body composition refers to the amount of muscle and fluid in the body, which can significantly change during serious illness. Using ultrasound is beneficial because it is portable, can be used right at the bedside, and does not involve radiation, making it particularly suitable for women in critical care, especially during pregnancy or related gynecological issues.
To participate in this trial, women aged 16 and older who are admitted to the obstetrics and gynecology critical care unit may be eligible, provided they have certain health classifications (ASA class I, II, or III). If a patient chooses not to participate, that’s perfectly okay. Those who do join the study can expect to undergo ultrasound assessments to monitor their body composition safely while they receive care. This trial aims to improve how we understand and manage health changes in critically ill women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • females with age 16 with no upper limit
- • American Society of Anesthesiologists (ASA) class I, II or III,
- • admitted to the obstetrics and Gynecology critical care unit
- Exclusion Criteria:
- • Patient refusal
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Abbasia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported